Australia markets open in 7 hours 27 minutes

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.43-0.12 (-2.16%)
As of 11:32AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts22222320
Avg. Estimate-0.62-0.6-2.14-1.71
Low estimate-1.06-0.94-2.97-2.41
High estimate-0.15-0.19-1.11-0.89
Year ago EPS-0.68-0.79-2.91-2.14
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts19192320
Avg. Estimate33.18M6.1M49.55M22.62M
Low estimateN/AN/AN/AN/A
High estimate72.3M21.69M124.36M89M
Year ago sales18.41M18.55M96.3M49.55M
Sales growth (year/est)80.20%-67.10%-48.50%-54.30%
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS-0.76-0.83-0.89-0.86
Actual EPS-0.68-0.79-0.86-0.58
Difference0.080.040.030.28
Surprise %10.50%4.80%3.40%32.60%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate-0.62-0.6-2.14-1.71
7 days ago-0.62-0.6-2.14-1.71
30 days ago-0.68-0.54-2.09-1.74
60 days ago-0.68-0.54-2.09-1.74
90 days ago-0.94-0.97-3.92-4.04
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days9586
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesFATEIndustrySector(s)S&P 500
Current qtr.8.80%N/AN/AN/A
Next qtr.24.10%N/AN/AN/A
Current year26.50%N/AN/AN/A
Next year20.10%N/AN/AN/A
Next 5 years (per annum)-37.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A